Thereafter it ran into Food and Drug Administration (FDA) and judicial obstacles (mainly concerning the methods and viability of the vaccine manufactured by BioPort, a subsidiary of Emergent BioSolutions Inc.).
He also served on the board of Emergent BioSolutions (then Bioport), a company that provided controversial anthrax vaccinations to the U.S. military in the 1990s.